nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—HTR1A—bipolar disorder	0.909	1	CbGaD
Lofexidine—HTR1A—telencephalic ventricle—bipolar disorder	0.00474	0.388	CbGeAlD
Lofexidine—HTR1A—blood plasma—bipolar disorder	0.00226	0.185	CbGeAlD
Lofexidine—ADRA2A—blood plasma—bipolar disorder	0.00158	0.129	CbGeAlD
Lofexidine—HTR1A—nervous system—bipolar disorder	0.000672	0.0549	CbGeAlD
Lofexidine—HTR1A—cerebellum—bipolar disorder	0.000632	0.0517	CbGeAlD
Lofexidine—ADRA2A—Monoamine GPCRs—HTR2A—bipolar disorder	0.000609	0.00779	CbGpPWpGaD
Lofexidine—ADRA2A—Regulation of insulin secretion—CACNA1C—bipolar disorder	0.000577	0.00737	CbGpPWpGaD
Lofexidine—ADRA2A—thyroid gland—bipolar disorder	0.00056	0.0458	CbGeAlD
Lofexidine—HTR1A—brain—bipolar disorder	0.000514	0.042	CbGeAlD
Lofexidine—ADRA2A—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.000512	0.00655	CbGpPWpGaD
Lofexidine—ADRA2A—Regulation of insulin secretion—SNAP25—bipolar disorder	0.000504	0.00645	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.000501	0.0064	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—CACNB2—bipolar disorder	0.000496	0.00634	CbGpPWpGaD
Lofexidine—ADRA2A—nervous system—bipolar disorder	0.000471	0.0385	CbGeAlD
Lofexidine—HTR1A—G alpha (i) signalling events—RGS4—bipolar disorder	0.000457	0.00585	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.000456	0.00583	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.000456	0.00583	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—CACNA1C—bipolar disorder	0.000454	0.0058	CbGpPWpGaD
Lofexidine—ADRA2A—cerebellum—bipolar disorder	0.000443	0.0362	CbGeAlD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.000433	0.00553	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—DGKH—bipolar disorder	0.000421	0.00538	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—SNAP25—bipolar disorder	0.000396	0.00507	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.000372	0.00475	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.000371	0.00474	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.000365	0.00466	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.000365	0.00466	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.000365	0.00466	CbGpPWpGaD
Lofexidine—ADRA2A—brain—bipolar disorder	0.00036	0.0294	CbGeAlD
Lofexidine—ADRA2A—G alpha (i) signalling events—RGS4—bipolar disorder	0.00036	0.0046	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.000355	0.00453	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—ADCY2—bipolar disorder	0.000351	0.00449	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00034	0.00435	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—TRPC3—bipolar disorder	0.000292	0.00373	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.000291	0.00373	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—DRD5—bipolar disorder	0.000282	0.00361	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.000274	0.00351	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.000265	0.00338	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.000261	0.00334	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.000261	0.00334	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—SERPINA1—bipolar disorder	0.000255	0.00326	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—DRD3—bipolar disorder	0.000254	0.00325	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—DRD4—bipolar disorder	0.000247	0.00316	CbGpPWpGaD
Lofexidine—ADRA2A—Regulation of insulin secretion—INS—bipolar disorder	0.000246	0.00314	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000244	0.00312	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.000244	0.00312	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000236	0.00302	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000234	0.00299	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—ADCY2—bipolar disorder	0.000233	0.00297	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—DRD2—bipolar disorder	0.00023	0.00294	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.000229	0.00293	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000224	0.00286	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—DRD5—bipolar disorder	0.000222	0.00284	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—DGKH—bipolar disorder	0.000217	0.00277	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—HTR1A—bipolar disorder	0.000214	0.00273	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.000214	0.00273	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.000213	0.00272	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.000209	0.00267	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.000209	0.00267	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.000205	0.00263	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.000205	0.00263	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—ADM—bipolar disorder	0.000204	0.00261	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.000202	0.00259	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—DRD3—bipolar disorder	0.0002	0.00256	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—TSHB—bipolar disorder	0.000199	0.00254	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—TACR1—bipolar disorder	0.000199	0.00254	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.000198	0.00254	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.000196	0.00251	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—DRD4—bipolar disorder	0.000194	0.00248	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—INS—bipolar disorder	0.000193	0.00247	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000192	0.00245	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.000192	0.00245	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000186	0.00237	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.000183	0.00234	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—ADCY2—bipolar disorder	0.000183	0.00234	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—DRD2—bipolar disorder	0.000181	0.00231	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00018	0.0023	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—DGKH—bipolar disorder	0.000175	0.00223	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—IMPA2—bipolar disorder	0.000172	0.0022	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00017	0.00217	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.000168	0.00215	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.000167	0.00214	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.000164	0.0021	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.000164	0.0021	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—TAC1—bipolar disorder	0.000162	0.00207	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—ADM—bipolar disorder	0.00016	0.00205	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—DRD5—bipolar disorder	0.00016	0.00204	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—HTR2C—bipolar disorder	0.000159	0.00203	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—DRD1—bipolar disorder	0.000159	0.00203	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.000159	0.00203	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—DGKH—bipolar disorder	0.000158	0.00203	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—RGS4—bipolar disorder	0.000157	0.002	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—TSHB—bipolar disorder	0.000156	0.002	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—TACR1—bipolar disorder	0.000156	0.002	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.000154	0.00197	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—DRD3—bipolar disorder	0.000154	0.00197	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TRPC3—bipolar disorder	0.00015	0.00192	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00015	0.00191	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—DRD4—bipolar disorder	0.00015	0.00191	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—DRD5—bipolar disorder	0.000145	0.00185	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.000144	0.00184	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—RGS4—bipolar disorder	0.000142	0.00182	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—DRD2—bipolar disorder	0.000139	0.00178	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—DGKH—bipolar disorder	0.000137	0.00175	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000133	0.00169	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SERPINA1—bipolar disorder	0.000131	0.00168	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR1A—bipolar disorder	0.000129	0.00166	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—POMC—bipolar disorder	0.000129	0.00165	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000128	0.00164	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—TAC1—bipolar disorder	0.000127	0.00163	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—DRD5—bipolar disorder	0.000125	0.0016	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—DRD1—bipolar disorder	0.000125	0.0016	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR2C—bipolar disorder	0.000125	0.0016	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—DGKH—bipolar disorder	0.000125	0.00159	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—RGS4—bipolar disorder	0.000123	0.00157	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—DRD3—bipolar disorder	0.000121	0.00155	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—TRPC3—bipolar disorder	0.000121	0.00155	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.000118	0.0015	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—DRD4—bipolar disorder	0.000118	0.0015	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—IMPA1—bipolar disorder	0.000116	0.00148	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADM—bipolar disorder	0.000115	0.00148	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—DRD5—bipolar disorder	0.000114	0.00146	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PDE4B—bipolar disorder	0.000112	0.00144	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—TACR1—bipolar disorder	0.000112	0.00144	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—TSHB—bipolar disorder	0.000112	0.00144	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—GATA3—bipolar disorder	0.000112	0.00143	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—RGS4—bipolar disorder	0.000112	0.00143	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—TRPC3—bipolar disorder	0.00011	0.0014	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—DRD2—bipolar disorder	0.00011	0.0014	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADM—bipolar disorder	0.000105	0.00134	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000102	0.00131	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PDE4B—bipolar disorder	0.000102	0.00131	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—TSHB—bipolar disorder	0.000102	0.00131	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—TACR1—bipolar disorder	0.000102	0.00131	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKR1C4—bipolar disorder	0.000102	0.0013	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—POMC—bipolar disorder	0.000101	0.00129	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000101	0.00129	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NDUFV2—bipolar disorder	9.87e-05	0.00126	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—HTR2A—bipolar disorder	9.76e-05	0.00125	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKR1C4—bipolar disorder	9.56e-05	0.00122	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—TRPC3—bipolar disorder	9.51e-05	0.00122	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DGKH—bipolar disorder	9.36e-05	0.0012	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—TAC1—bipolar disorder	9.17e-05	0.00117	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADM—bipolar disorder	9.07e-05	0.00116	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—DRD1—bipolar disorder	8.99e-05	0.00115	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR2C—bipolar disorder	8.99e-05	0.00115	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PDE4B—bipolar disorder	8.84e-05	0.00113	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—TSHB—bipolar disorder	8.84e-05	0.00113	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—TACR1—bipolar disorder	8.84e-05	0.00113	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—DRD3—bipolar disorder	8.71e-05	0.00111	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—TRPC3—bipolar disorder	8.63e-05	0.0011	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NR1D1—bipolar disorder	8.59e-05	0.0011	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DRD5—bipolar disorder	8.56e-05	0.00109	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—DRD4—bipolar disorder	8.45e-05	0.00108	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RGS4—bipolar disorder	8.4e-05	0.00107	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—TAC1—bipolar disorder	8.32e-05	0.00106	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADM—bipolar disorder	8.24e-05	0.00105	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NCAN—bipolar disorder	8.21e-05	0.00105	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—DRD1—bipolar disorder	8.16e-05	0.00104	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR2C—bipolar disorder	8.16e-05	0.00104	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SLC5A3—bipolar disorder	8.05e-05	0.00103	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	8.04e-05	0.00103	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PDE4B—bipolar disorder	8.03e-05	0.00103	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—TSHB—bipolar disorder	8.03e-05	0.00103	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—TACR1—bipolar disorder	8.03e-05	0.00103	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKR1C4—bipolar disorder	7.99e-05	0.00102	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADCY2—bipolar disorder	7.96e-05	0.00102	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—DRD3—bipolar disorder	7.91e-05	0.00101	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—DRD2—bipolar disorder	7.87e-05	0.00101	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—POMC—bipolar disorder	7.79e-05	0.000996	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—DRD4—bipolar disorder	7.68e-05	0.000981	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR2A—bipolar disorder	7.67e-05	0.000981	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DGKH—bipolar disorder	7.36e-05	0.000941	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR1A—bipolar disorder	7.32e-05	0.000935	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADCY2—bipolar disorder	7.22e-05	0.000924	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—TAC1—bipolar disorder	7.2e-05	0.000921	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—DRD2—bipolar disorder	7.15e-05	0.000914	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR2C—bipolar disorder	7.07e-05	0.000903	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—DRD1—bipolar disorder	7.07e-05	0.000903	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—DRD3—bipolar disorder	6.84e-05	0.000875	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DRD5—bipolar disorder	6.73e-05	0.00086	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR1A—bipolar disorder	6.64e-05	0.000849	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—DRD4—bipolar disorder	6.64e-05	0.000849	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RGS4—bipolar disorder	6.6e-05	0.000844	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—TAC1—bipolar disorder	6.54e-05	0.000836	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TRPC3—bipolar disorder	6.49e-05	0.00083	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR2C—bipolar disorder	6.42e-05	0.00082	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—DRD1—bipolar disorder	6.42e-05	0.00082	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADCY2—bipolar disorder	6.25e-05	0.000799	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—DRD3—bipolar disorder	6.21e-05	0.000794	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADM—bipolar disorder	6.19e-05	0.000791	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—DRD2—bipolar disorder	6.19e-05	0.000791	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	6.13e-05	0.000783	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	6.03e-05	0.000771	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TSHB—bipolar disorder	6.03e-05	0.000771	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDE4B—bipolar disorder	6.03e-05	0.000771	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TACR1—bipolar disorder	6.03e-05	0.000771	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CLOCK—bipolar disorder	5.82e-05	0.000744	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	5.68e-05	0.000726	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TPH2—bipolar disorder	5.67e-05	0.000725	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CACNB2—bipolar disorder	5.67e-05	0.000725	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TSHB—bipolar disorder	5.67e-05	0.000725	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	5.62e-05	0.000718	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—DPYD—bipolar disorder	5.58e-05	0.000713	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR2A—bipolar disorder	5.51e-05	0.000705	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CACNA1C—bipolar disorder	5.19e-05	0.000663	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	5.1e-05	0.000652	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	5.05e-05	0.000646	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	5.01e-05	0.00064	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TAC1—bipolar disorder	4.92e-05	0.000629	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADM—bipolar disorder	4.87e-05	0.000622	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	4.82e-05	0.000617	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DRD1—bipolar disorder	4.82e-05	0.000617	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	4.74e-05	0.000606	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	4.74e-05	0.000606	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	4.74e-05	0.000606	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	4.69e-05	0.0006	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DRD3—bipolar disorder	4.67e-05	0.000597	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	4.65e-05	0.000594	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DRD4—bipolar disorder	4.53e-05	0.00058	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SNAP25—bipolar disorder	4.53e-05	0.00058	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	4.4e-05	0.000563	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	4.33e-05	0.000554	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	4.27e-05	0.000546	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	4.25e-05	0.000544	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DRD2—bipolar disorder	4.22e-05	0.00054	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ADCY2—bipolar disorder	4.01e-05	0.000513	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—POMC—bipolar disorder	4e-05	0.000511	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	3.94e-05	0.000503	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	3.92e-05	0.000502	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	3.86e-05	0.000494	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	3.82e-05	0.000489	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	3.79e-05	0.000485	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	3.79e-05	0.000485	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—S100B—bipolar disorder	3.72e-05	0.000475	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	3.69e-05	0.000471	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	3.67e-05	0.000469	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	3.65e-05	0.000467	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	3.56e-05	0.000456	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	3.46e-05	0.000443	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—COMT—bipolar disorder	3.44e-05	0.000439	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MAOA—bipolar disorder	3.41e-05	0.000436	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	3.35e-05	0.000429	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	3.34e-05	0.000427	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	3.32e-05	0.000424	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NRG1—bipolar disorder	3.28e-05	0.000419	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	3.14e-05	0.000402	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	3.01e-05	0.000384	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	2.96e-05	0.000378	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—S100B—bipolar disorder	2.92e-05	0.000374	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MTHFR—bipolar disorder	2.78e-05	0.000355	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	2.58e-05	0.00033	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	2.38e-05	0.000304	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—POMC—bipolar disorder	2.36e-05	0.000302	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—INS—bipolar disorder	2.35e-05	0.0003	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	2.33e-05	0.000297	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—POMC—bipolar disorder	2.22e-05	0.000284	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—INS—bipolar disorder	2.21e-05	0.000282	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	1.87e-05	0.000239	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—POMC—bipolar disorder	1.86e-05	0.000237	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—INS—bipolar disorder	1.85e-05	0.000236	CbGpPWpGaD
